MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Quest Diagnostics Incorporated Total Current Liabilities 2011-2026 | DGX
Annual Total Current Liabilities Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.28 B | 2.17 B | 1.82 B | 1.55 B | 1.75 B | 1.78 B | 1.99 B | 1.48 B | 1.06 B | 981 M | 1.17 B | 1.71 B | 1.13 B | 1.05 B | 1.56 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.28 B | 981 M | 1.57 B |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.31 | -19.63 % | $ 1.74 M |  USA |
 |
Agilent Technologies
A
|
1.71 B | $ 112.11 | -1.0 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
68.7 M | $ 19.11 | 1.19 % | $ 554 M | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 15.85 | -2.1 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 142.72 | -0.36 % | $ 22.7 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 93.78 | -2.99 % | $ 6.33 B | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 418.32 | -0.2 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 038.75 | -0.3 % | $ 21.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
134 M | $ 3.62 | - | $ 335 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.29 | -0.9 % | $ 1.06 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 152.19 | -4.36 % | $ 7.54 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 18.61 | -1.69 % | $ 417 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
310 M | $ 188.15 | -4.45 % | $ 18.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
303 M | $ 94.27 | -4.45 % | $ 11.8 B | USA |
 |
Personalis
PSNL
|
39.6 M | $ 6.38 | -4.92 % | $ 569 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 116.56 | -0.45 % | $ 9.61 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 5.72 | -1.72 % | $ 239 M | USA |
 |
Soleno Therapeutics
SLNO
|
61.4 M | $ 53.0 | 0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
1.74 M | $ 2.25 | -6.67 % | $ 5.17 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 252.68 | -0.53 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 438.85 | -2.07 % | $ 165 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 135.17 | 0.33 % | $ 6.32 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 48.65 | -8.12 % | $ 2.91 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 8.21 | -2.61 % | $ 1.78 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |